Several things to address here. Okeido you have no reason to explain buying or selling your shares, you have every right to buy and sell as you see fit, don't worry about what people on a forum will say about it. Welcome back. The article by Dr. Fleet is interesting, as far as the contract with dongfeng mentioned they did have a contract initially to provide the prototype battery systems http://www.marketwired.com/press-release/Electrovaya-receives-Purchase-Order-Lithium-Ion-SuperPolymer-batteries-from-DongFeng-TSX-EFL-1746147.htm That being said I think he may have let it slip about a contract with them. Also in the article he mentions electrovaya's growth will be a combination of licensing agreements and direct production. He goes on to mention a recent non-exclusive licensing agreement with Tata Motors. They had a licensing agreement with Tata but that was a couple of years ago, I wouldn't refer to that as recent. I have no doubt that they have a major deal with at least one auto OEM and I suspect more than one. I think it is the only way to explain the over 100 million revenue pipeline. As far as the safety benefits of lithium iron phosphate superpolymer batteries there is no such thing, electrovaya does not use LifeP04 they use lithium manganese. He also mentions they are able to produce the batteries at well under $200/kwh, this is the big benefit of electrovaya's batteries. Imagine the cost if they build a plant in China or India. Battery costs that low were not predicted for years, couple that with very competitive battery performance and you have a winner.